Osteoarthritis Drugs
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global P2X7 Receptor Antagonists Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 GSK1482160 1.2.3 AZD9056 1.2.4 EVT 401 1.2.5 JNJ 55308942 & JNJ 54175446 1.2.6 AKP-23494954/RQ-00466479 1.2.7 Others 1.3 Market by Application 1.3.1 Global P2X7 Receptor Antagonists Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Inflammatory Diseases 1.3.3 Central Nervous System Diseases 1.3.4 Immune System Disorders 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global P2X7 Receptor Antagonists Market Perspective (2017-2028) 2.2 P2X7 Receptor Antagonists Growth Trends by Region 2.2.1 P2X7 Receptor Antagonists Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 P2X7 Receptor Antagonists Historic Market Size by Region (2017-2022) 2.2.3 P2X7 Receptor Antagonists Forecasted Market Size by Region (2023-2028) 2.3 P2X7 Receptor Antagonists Market Dynamics 2.3.1 P2X7 Receptor Antagonists Industry Trends 2.3.2 P2X7 Receptor Antagonists Market Drivers 2.3.3 P2X7 Receptor Antagonists Market Challenges 2.3.4 P2X7 Receptor Antagonists Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top P2X7 Receptor Antagonists Players by Revenue 3.1.1 Global Top P2X7 Receptor Antagonists Players by Revenue (2017-2022) 3.1.2 Global P2X7 Receptor Antagonists Revenue Market Share by Players (2017-2022) 3.2 Global P2X7 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by P2X7 Receptor Antagonists Revenue 3.4 Global P2X7 Receptor Antagonists Market Concentration Ratio 3.4.1 Global P2X7 Receptor Antagonists Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by P2X7 Receptor Antagonists Revenue in 2021 3.5 P2X7 Receptor Antagonists Key Players Head office and Area Served 3.6 Key Players P2X7 Receptor Antagonists Product Solution and Service 3.7 Date of Enter into P2X7 Receptor Antagonists Market 3.8 Mergers & Acquisitions, Expansion Plans 4 P2X7 Receptor Antagonists Breakdown Data by Type 4.1 Global P2X7 Receptor Antagonists Historic Market Size by Type (2017-2022) 4.2 Global P2X7 Receptor Antagonists Forecasted Market Size by Type (2023-2028) 5 P2X7 Receptor Antagonists Breakdown Data by Application 5.1 Global P2X7 Receptor Antagonists Historic Market Size by Application (2017-2022) 5.2 Global P2X7 Receptor Antagonists Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America P2X7 Receptor Antagonists Market Size (2017-2028) 6.2 North America P2X7 Receptor Antagonists Market Size by Country (2017-2022) 6.3 North America P2X7 Receptor Antagonists Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe P2X7 Receptor Antagonists Market Size (2017-2028) 7.2 Europe P2X7 Receptor Antagonists Market Size by Country (2017-2022) 7.3 Europe P2X7 Receptor Antagonists Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific P2X7 Receptor Antagonists Market Size (2017-2028) 8.2 Asia-Pacific P2X7 Receptor Antagonists Market Size by Country (2017-2022) 8.3 Asia-Pacific P2X7 Receptor Antagonists Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America P2X7 Receptor Antagonists Market Size (2017-2028) 9.2 Latin America P2X7 Receptor Antagonists Market Size by Country (2017-2022) 9.3 Latin America P2X7 Receptor Antagonists Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa P2X7 Receptor Antagonists Market Size (2017-2028) 10.2 Middle East & Africa P2X7 Receptor Antagonists Market Size by Country (2017-2022) 10.3 Middle East & Africa P2X7 Receptor Antagonists Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Company Detail 11.1.2 GlaxoSmithKline Business Overview 11.1.3 GlaxoSmithKline P2X7 Receptor Antagonists Introduction 11.1.4 GlaxoSmithKline Revenue in P2X7 Receptor Antagonists Business (2017-2022) 11.1.5 GlaxoSmithKline Recent Development 11.2 AstraZeneca 11.2.1 AstraZeneca Company Detail 11.2.2 AstraZeneca Business Overview 11.2.3 AstraZeneca P2X7 Receptor Antagonists Introduction 11.2.4 AstraZeneca Revenue in P2X7 Receptor Antagonists Business (2017-2022) 11.2.5 AstraZeneca Recent Development 11.3 Janssen 11.3.1 Janssen Company Detail 11.3.2 Janssen Business Overview 11.3.3 Janssen P2X7 Receptor Antagonists Introduction 11.3.4 Janssen Revenue in P2X7 Receptor Antagonists Business (2017-2022) 11.3.5 Janssen Recent Development 11.4 RaQualia Pharma 11.4.1 RaQualia Pharma Company Detail 11.4.2 RaQualia Pharma Business Overview 11.4.3 RaQualia Pharma P2X7 Receptor Antagonists Introduction 11.4.4 RaQualia Pharma Revenue in P2X7 Receptor Antagonists Business (2017-2022) 11.4.5 RaQualia Pharma Recent Development 11.5 Evotec 11.5.1 Evotec Company Detail 11.5.2 Evotec Business Overview 11.5.3 Evotec P2X7 Receptor Antagonists Introduction 11.5.4 Evotec Revenue in P2X7 Receptor Antagonists Business (2017-2022) 11.5.5 Evotec Recent Development 11.6 Asahi Kasei Pharma 11.6.1 Asahi Kasei Pharma Company Detail 11.6.2 Asahi Kasei Pharma Business Overview 11.6.3 Asahi Kasei Pharma P2X7 Receptor Antagonists Introduction 11.6.4 Asahi Kasei Pharma Revenue in P2X7 Receptor Antagonists Business (2017-2022) 11.6.5 Asahi Kasei Pharma Recent Development 11.7 Pfizer 11.7.1 Pfizer Company Detail 11.7.2 Pfizer Business Overview 11.7.3 Pfizer P2X7 Receptor Antagonists Introduction 11.7.4 Pfizer Revenue in P2X7 Receptor Antagonists Business (2017-2022) 11.7.5 Pfizer Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global P2X7 Receptor Antagonists Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of GSK1482160 Table 3. Key Players of AZD9056 Table 4. Key Players of EVT 401 Table 5. Key Players of JNJ 55308942 & JNJ 54175446 Table 6. Key Players of AKP-23494954/RQ-00466479 Table 7. Key Players of Others Table 8. Global P2X7 Receptor Antagonists Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global P2X7 Receptor Antagonists Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 10. Global P2X7 Receptor Antagonists Market Size by Region (2017-2022) & (US$ Million) Table 11. Global P2X7 Receptor Antagonists Market Share by Region (2017-2022) Table 12. Global P2X7 Receptor Antagonists Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 13. Global P2X7 Receptor Antagonists Market Share by Region (2023-2028) Table 14. P2X7 Receptor Antagonists Market Trends Table 15. P2X7 Receptor Antagonists Market Drivers Table 16. P2X7 Receptor Antagonists Market Challenges Table 17. P2X7 Receptor Antagonists Market Restraints Table 18. Global P2X7 Receptor Antagonists Revenue by Players (2017-2022) & (US$ Million) Table 19. Global P2X7 Receptor Antagonists Market Share by Players (2017-2022) Table 20. Global Top P2X7 Receptor Antagonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in P2X7 Receptor Antagonists as of 2021) Table 21. Ranking of Global Top P2X7 Receptor Antagonists Companies by Revenue (US$ Million) in 2021 Table 22. Global 5 Largest Players Market Share by P2X7 Receptor Antagonists Revenue (CR5 and HHI) & (2017-2022) Table 23. Key Players Headquarters and Area Served Table 24. Key Players P2X7 Receptor Antagonists Product Solution and Service Table 25. Date of Enter into P2X7 Receptor Antagonists Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global P2X7 Receptor Antagonists Market Size by Type (2017-2022) & (US$ Million) Table 28. Global P2X7 Receptor Antagonists Revenue Market Share by Type (2017-2022) Table 29. Global P2X7 Receptor Antagonists Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 30. Global P2X7 Receptor Antagonists Revenue Market Share by Type (2023-2028) Table 31. Global P2X7 Receptor Antagonists Market Size by Application (2017-2022) & (US$ Million) Table 32. Global P2X7 Receptor Antagonists Revenue Market Share by Application (2017-2022) Table 33. Global P2X7 Receptor Antagonists Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 34. Global P2X7 Receptor Antagonists Revenue Market Share by Application (2023-2028) Table 35. North America P2X7 Receptor Antagonists Market Size by Country (2017-2022) & (US$ Million) Table 36. North America P2X7 Receptor Antagonists Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe P2X7 Receptor Antagonists Market Size by Country (2017-2022) & (US$ Million) Table 38. Europe P2X7 Receptor Antagonists Market Size by Country (2023-2028) & (US$ Million) Table 39. Asia-Pacific P2X7 Receptor Antagonists Market Size by Region (2017-2022) & (US$ Million) Table 40. Asia-Pacific P2X7 Receptor Antagonists Market Size by Region (2023-2028) & (US$ Million) Table 41. Latin America P2X7 Receptor Antagonists Market Size by Country (2017-2022) & (US$ Million) Table 42. Latin America P2X7 Receptor Antagonists Market Size by Country (2023-2028) & (US$ Million) Table 43. Middle East & Africa P2X7 Receptor Antagonists Market Size by Country (2017-2022) & (US$ Million) Table 44. Middle East & Africa P2X7 Receptor Antagonists Market Size by Country (2023-2028) & (US$ Million) Table 45. GlaxoSmithKline Company Detail Table 46. GlaxoSmithKline Business Overview Table 47. GlaxoSmithKline P2X7 Receptor Antagonists Product Table 48. GlaxoSmithKline Revenue in P2X7 Receptor Antagonists Business (2017-2022) & (US$ Million) Table 49. GlaxoSmithKline Recent Development Table 50. AstraZeneca Company Detail Table 51. AstraZeneca Business Overview Table 52. AstraZeneca P2X7 Receptor Antagonists Product Table 53. AstraZeneca Revenue in P2X7 Receptor Antagonists Business (2017-2022) & (US$ Million) Table 54. AstraZeneca Recent Development Table 55. Janssen Company Detail Table 56. Janssen Business Overview Table 57. Janssen P2X7 Receptor Antagonists Product Table 58. Janssen Revenue in P2X7 Receptor Antagonists Business (2017-2022) & (US$ Million) Table 59. Janssen Recent Development Table 60. RaQualia Pharma Company Detail Table 61. RaQualia Pharma Business Overview Table 62. RaQualia Pharma P2X7 Receptor Antagonists Product Table 63. RaQualia Pharma Revenue in P2X7 Receptor Antagonists Business (2017-2022) & (US$ Million) Table 64. RaQualia Pharma Recent Development Table 65. Evotec Company Detail Table 66. Evotec Business Overview Table 67. Evotec P2X7 Receptor Antagonists Product Table 68. Evotec Revenue in P2X7 Receptor Antagonists Business (2017-2022) & (US$ Million) Table 69. Evotec Recent Development Table 70. Asahi Kasei Pharma Company Detail Table 71. Asahi Kasei Pharma Business Overview Table 72. Asahi Kasei Pharma P2X7 Receptor Antagonists Product Table 73. Asahi Kasei Pharma Revenue in P2X7 Receptor Antagonists Business (2017-2022) & (US$ Million) Table 74. Asahi Kasei Pharma Recent Development Table 75. Pfizer Company Detail Table 76. Pfizer Business Overview Table 77. Pfizer P2X7 Receptor Antagonists Product Table 78. Pfizer Revenue in P2X7 Receptor Antagonists Business (2017-2022) & (US$ Million) Table 79. Pfizer Recent Development Table 80. Research Programs/Design for This Report Table 81. Key Data Information from Secondary Sources Table 82. Key Data Information from Primary Sources List of Figures Figure 1. Global P2X7 Receptor Antagonists Market Share by Type: 2021 VS 2028 Figure 2. GSK1482160 Features Figure 3. AZD9056 Features Figure 4. EVT 401 Features Figure 5. JNJ 55308942 & JNJ 54175446 Features Figure 6. AKP-23494954/RQ-00466479 Features Figure 7. Others Features Figure 8. Global P2X7 Receptor Antagonists Market Share by Application in 2021 & 2028 Figure 9. Inflammatory Diseases Case Studies Figure 10. Central Nervous System Diseases Case Studies Figure 11. Immune System Disorders Case Studies Figure 12. P2X7 Receptor Antagonists Report Years Considered Figure 13. Global P2X7 Receptor Antagonists Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 14. Global P2X7 Receptor Antagonists Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global P2X7 Receptor Antagonists Market Share by Region: 2021 VS 2028 Figure 16. Global P2X7 Receptor Antagonists Market Share by Players in 2021 Figure 17. Global Top P2X7 Receptor Antagonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in P2X7 Receptor Antagonists as of 2021) Figure 18. The Top 10 and 5 Players Market Share by P2X7 Receptor Antagonists Revenue in 2021 Figure 19. North America P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. North America P2X7 Receptor Antagonists Market Share by Country (2017-2028) Figure 21. United States P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe P2X7 Receptor Antagonists Market Share by Country (2017-2028) Figure 25. Germany P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. France P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. U.K. P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Italy P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Russia P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Nordic Countries P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific P2X7 Receptor Antagonists Market Share by Region (2017-2028) Figure 33. China P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Japan P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. South Korea P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Southeast Asia P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. India P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Australia P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Latin America P2X7 Receptor Antagonists Market Share by Country (2017-2028) Figure 41. Mexico P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Brazil P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Middle East & Africa P2X7 Receptor Antagonists Market Share by Country (2017-2028) Figure 45. Turkey P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Saudi Arabia P2X7 Receptor Antagonists Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. GlaxoSmithKline Revenue Growth Rate in P2X7 Receptor Antagonists Business (2017-2022) Figure 48. AstraZeneca Revenue Growth Rate in P2X7 Receptor Antagonists Business (2017-2022) Figure 49. Janssen Revenue Growth Rate in P2X7 Receptor Antagonists Business (2017-2022) Figure 50. RaQualia Pharma Revenue Growth Rate in P2X7 Receptor Antagonists Business (2017-2022) Figure 51. Evotec Revenue Growth Rate in P2X7 Receptor Antagonists Business (2017-2022) Figure 52. Asahi Kasei Pharma Revenue Growth Rate in P2X7 Receptor Antagonists Business (2017-2022) Figure 53. Pfizer Revenue Growth Rate in P2X7 Receptor Antagonists Business (2017-2022) Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed
GlaxoSmithKline AstraZeneca Janssen RaQualia Pharma Evotec Asahi Kasei Pharma Pfizer
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More